Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-24 @ 7:45 PM
NCT ID:
NCT00675103
Eligibility Criteria:
Inclusion Criteria:
* Previous treatment in studies of pegloticase i.v.
* Last exposure to pegloticase i.v. greater than one year prior to study entry
* Symptomatic gout
* Documented hyperuricemic (SUA ≥ 7 mg/dL)
Exclusion Criteria:
* Prior exposure to Elitek® (rasburicase)
* Unstable angina
* Uncontrolled arrhythmia or hypertension
* Non-compensated congestive heart failure
* End stage renal disease requiring dialysis
* Concomitant use of SUA lowering agents and use of other investigational drugs
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00675103
Study Brief:
Protocol Section:
NCT00675103